- Home
- PFE vs BSX Comparison
PFE vs BSX Comparison
Compare PFE & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFE
- BSX
- Stock Information
- Founded
- PFE 1849
- BSX 1979
- Country
- PFE United States
- BSX United States
- Employees
- PFE N/A
- BSX N/A
- Industry
- PFE Biotechnology: Pharmaceutical Preparations
- BSX Medical/Dental Instruments
- Sector
- PFE Health Care
- BSX Health Care
- Exchange
- PFE Nasdaq
- BSX Nasdaq
- Market Cap
- PFE 140.8B
- BSX 157.6B
- IPO Year
- PFE N/A
- BSX 1992
- Fundamental
- Price
- PFE $24.04
- BSX $98.50
- Analyst Decision
- PFE Hold
- BSX Strong Buy
- Analyst Count
- PFE 12
- BSX 22
- Target Price
- PFE $29.36
- BSX $118.91
- AVG Volume (30 Days)
- PFE 41.5M
- BSX 7.8M
- Earning Date
- PFE 10-28-2025
- BSX 10-22-2025
- Dividend Yield
- PFE 7.16%
- BSX N/A
- EPS Growth
- PFE N/A
- BSX 36.90
- EPS
- PFE 1.89
- BSX 1.68
- Revenue
- PFE $63,833,000,000.00
- BSX $18,494,000,000.00
- Revenue This Year
- PFE $0.35
- BSX $19.75
- Revenue Next Year
- PFE N/A
- BSX $11.03
- P/E Ratio
- PFE $12.69
- BSX $58.59
- Revenue Growth
- PFE 13.53
- BSX 21.44
- 52 Week Low
- PFE $20.92
- BSX $80.64
- 52 Week High
- PFE $30.43
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- PFE 42.35
- BSX 28.49
- Support Level
- PFE $23.68
- BSX $104.24
- Resistance Level
- PFE $24.86
- BSX $109.50
- Average True Range (ATR)
- PFE 0.45
- BSX 2.11
- MACD
- PFE -0.12
- BSX -1.00
- Stochastic Oscillator
- PFE 25.00
- BSX 8.52
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.